Disease Studies

Neuropsychiatric Drug Development Summit

Online, 29-30 September 2021

Members of the PrecisionLife team will join leaders from the likes of Sunovion, Merck, Takeda, Lundbeck, BioXcel and MAPS online at the 4th Annual Neuropsychiatric Drug Development Summit to help us meet unmet needs in various neuropsychiatric disorders including schizophrenia, depression and bi-polar.

PrecisionLife is seeking to meet with collaborative R&D partners to progress our pipeline of precision medicine programs across a range of neuropsychiatric diseases.

Meet with us

Improve your likelihood of success with precision medicine enabled by unique combinatorial analytics

Neuropsychiatric Drug Development

More News & Media

View All News & Media

BIA Bioscience Forum

London, 14 October 2021 PrecisionLife CEO, Dr Steve Gardner, will join an expert panel at the BIA Bioscience Forum…

Read more

WEBINAR: Disease Mechanisms and Target Discovery

PrecisionLife CEO, Dr Steve Gardner, joins Cyclica CEO, Naheed Kurji in a webinar exploring Disease Mechanisms and Target Discovery….

Read more

Bio Digital 2021

10-11 June 2021 Accelerating a BIO-Revolution through global partnerships, collaboration, and thought leadership We are joining the the world’s…

Read more

Keep in touch

Please enter your email address if you would like to be kept informed of our work here at PrecisionLife. Note that our Privacy Policy and Terms & Conditions apply.

Contact us

If you have any questions or would like to speak to us in terms of potential collaborations or partnership opportunities, please get in touch using the form below or email info@precisionlife.com and we will get back to you as soon as we can. Note that our Privacy Policy and Terms & Conditions apply.


Unit 8b Bankside
Hanborough Business Park
Long Hanborough, OX29 8LJ


1 Broadway Fl 14
MA 02142-1187


Agern Allé 3


Chmielna 73m
00-801 Warszawa